First Cleveland Air Code overhaul in decades would target pollution, health disparities
One of the key changes proposed is the establishment of “cumulative impact” scores. They would represent the totality of ...
Regeneron, Sanofi announce Dupixent sBLA accepted for priority review by FDA
Regeneron (REGN) and Sanofi (SNY) announced that the FDA has accepted for priority review the supplemental biologics license application for ...
Healio4d
Rezpegaldesleukin gets FDA fast track designation for atopic dermatitis
The FDA has granted a fast track designation to rezpegaldesleukin for treating patients aged 12 years and older with moderate ...
Aclaris Therapeutics: History Of Failures, And Recent Acquisition Of A 'Blockbuster Potential' Molecule
Aclaris' stock has dropped nearly 70% since September 2023, reflecting its history of failures and dissipations. Explore more ...
Guide to life insurance
Life insurance is designed to provide financial protection for your chosen beneficiaries. Term life insurance is generally ...
Business Insider29d
Quoin Pharmaceuticals Announces Further Clinical Evidence of QRX003 Effectiveness in Netherton Syndrome
WINRS: Worst Itch Numeric Rating Scale, which measures the severity of itch on an 11-point ... as well as a pronounced predisposition to allergies, asthma, and eczema. Patients often suffer ...
thorax.bmj18d
Validity and responsiveness of the Daily- and Clinical visit-PROactive Physical Activity in COPD (D-PPAC and C-PPAC) instruments
Methods We used data from seven randomised controlled trials to evaluate D-PPAC and C-PPAC internal consistency and construct validity by sex, age groups, COPD severity ... were responsive to the self ...
thorax.bmj18d
Late mortality after acute hypoxic respiratory failure
Health status: limitations of five activities and six instrumental activities of daily living (IADLs/ADLs), self-rating of health ... to respiratory failure (congestive heart failure and ...
BMJ18d
HEART rate variability biofeedback for long COVID symptoms (HEARTLOC): protocol for a feasibility study
1 Self-rating of at least ‘moderate’ or ’severe’ on dysautonomia ... Any unstable cardiorespiratory disease that needs further medical interventions (except asthma management). The participant will ...
BMJ17d
Feasibility of a structured 3-minute walk test as a clinical decision tool for patients presenting to the emergency department with acute dyspnoea
The walk test was discontinued if at any time the patient experienced severe shortness of breath (modified Borg scale rating ⩾7),2 anterior chest ... tolerance for individuals with varying disease ...